echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > American Heart Association: Pregnancy complications or red flags for women suffering from heart disease

    American Heart Association: Pregnancy complications or red flags for women suffering from heart disease

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    About 10% to 15% of pregnant women will have adverse pregnancy outcomes, including risk factors related to cardiovascular disease, as well as some problems related to fetal health, such as low birth weight, older gestational age, and fetal growth restriction, etc.


    On March 29, a scientific statement issued by the American Heart Association in the "Circulation" today pointed out: pregnancy-related complications (hypertension, gestational diabetes, premature birth, small gestational age childbirth, pregnancy loss or placental dissection) may be Increase the risk of cardiovascular disease (CVD) in women in the future.


     

    Nisha I.


    Nisha I.


    The statement reported on the risks associated with several pregnancy complications:

    • Hypertension during pregnancy can increase the risk of cardiovascular disease in women by 67% and the risk of stroke by 83%.


      A healthy diet can improve the cardiovascular health of all women.


      Eating a diet that is good for heart health, sticking to good sleep and increasing physical activity, and continuing postpartum, may reduce the risk of cardiovascular disease .


      Lactation/breastfeeding may reduce the risk of cardiovascular disease and metabolic disease (including type 2 diabetes) in later life.


      "If a woman has these adverse pregnancy results, please closely monitor blood pressure, type 2 diabetes and blood lipid screening.


      The statement recommends that certain patients consider the use of preventive drug treatment as appropriate to better understand the effects of drugs that prevent cardiovascular disease in women with poor pregnancy.


      "Pregnancy and postpartum should be a "golden" opportunity for clinicians to identify disease risks in young women and work with them to improve cardiovascular health.


       



      Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.